Search This Blog

Thursday, October 31, 2019

Celgene EPS beats by $0.28, beats on revenue

Celgene (NASDAQ:CELG): Q3 Non-GAAP EPS of $2.99 beats by $0.28; GAAP EPS of $1.50 misses by $0.69.
Revenue of $4.52B (+16.2% Y/Y) beats by $130M.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.